Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Reexamination Certificate
2005-05-17
2005-05-17
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
C514S759000, C514S761000
Reexamination Certificate
active
06894079
ABSTRACT:
Disclosed are methods for reducing the injury to tissues, cells, microorganisms or lipids caused by free radicals. The method comprises exposing a composition comprising perfluorocarbon to the tissue, cell, microorganism or lipids in need of such a treatment. Perfluorocarbons may be used neat in solutions, as gases or as emulsions.
REFERENCES:
patent: 5284645 (1994-02-01), Long, Jr.
patent: 5437272 (1995-08-01), Fuhrman
patent: 5470885 (1995-11-01), Fuhrman et al.
patent: 5490498 (1996-02-01), Faithfull et al.
patent: 5655521 (1997-08-01), Faithfull et al.
patent: 5733939 (1998-03-01), Fuhrman et al.
patent: 6054311 (2000-04-01), Davey et al.
Smith et al., A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages, 1995, Critical Care Medicine, vol. 23 No. 9, p. 1533-1539.*
Lutz et al. “Combination of treatment with perfluorochemicals and free radical scavengers,” Biomaterials, artificial cells, and immobilization biotechnology, 1992, vol. 20, pp. 951-958, Medline Abstract, AN 93004173.*
Bekyarova, G. et al., Increased Antioxidant Capacity, Suppression of Free Radical Damage and Erythrocyte Aggregability After Combined Application of Alpha-Tocopherol and FC-43 Perfluorocarbon Emulsion in Early Postburn Period in Rats; Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1996, 24/6, pp. 629-641.
Ogilby, J.D., Cardiovascular Applications of Fluorocarbons: Current Status and Future Direction a Critical Clinical Appraisal; Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1994, 22/4, pp. 1083-1096.
Bekyarova, G., et al., Suppressive Effect of FC-43 Perfluorocarbon Emulsion on Enhanced Oxidative Haemolysis in the Early Postburn Phase; Burns, Mar. 1997; 23(2), pp. 117-121.
Bando, K., et al., Oxygenated Perfluorocarbon, Recombinant Human Superoxide Dismutase, and Catalase Amerliorate Free Radical Induced Myocardial Injury During Heart Preservation and Transplantation; Journal of Thoracic and Cardiovascular Surgery, 1988, 96/6, pp. 930-938.
Onishchenko, N.A., et al., Use of Perfluorocarbon Emulsion in Kidney Transplantation; Khirurgiia, Jun. 1990, (6), pp. 98-103.
Lutz et al.,Combination of Treatment with Perfluorochemicals and Free Radical Scavengers, Biomat., Art. Cells & Immob. Biotech., 1992, vol. 20(2-4), pp. 951-958.
Bekyarova et al.,Suppressive Effect of FC-43 Perfluorocarbon Emulsion on Enhanced Oxidative Haemolysis in the Early Postburn Phase, Burns, 1997, vol. 23, No. 2, pp. 117-121.
Fuhrman Bradley P.
Gunnersson Bjorn
Hernan Lynn J.
Rotta Alexandre T.
Steinhorn David M.
Hodgson & Russ LLP
Wang Shengjun
LandOfFree
Method for reducing free-radical induced injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing free-radical induced injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing free-radical induced injury will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3433860